Skip to main content
Toggle navigation
Login
Search
Home
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Back
Like
Tweet
Print
Anteneh Assefa Desalegn
Department of Pharmacy, University of Oslo, Norway
Poster(s):
(344) Interim results from the VAC4EU Post-Authorization Safety Study (PASS) among recipients of the Pfizer-BioNTech COVID-19 (Comirnaty®) vaccine in Europe
Tuesday, August 27, 2024
8:00 AM – 6:00 PM
CEST
(367) VAC4EU study to identify risk factors and characterize the clinical course of myocarditis/pericarditis following mRNA-1273 vaccination in four European countries: first descriptive analyses
Tuesday, August 27, 2024
8:00 AM – 6:00 PM
CEST
